Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Advertisement
U.S. markets open in 5 hours 52 minutes
S&P Futures
5,209.75
-5.00
(-0.10%)
Dow Futures
39,225.00
+2.00
(+0.01%)
Nasdaq Futures
18,187.75
-43.75
(-0.24%)
Russell 2000 Futures
2,047.90
-1.90
(-0.09%)
Crude Oil
82.70
-0.02
(-0.02%)
Gold
2,158.60
-5.70
(-0.26%)
Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
Visitors trend
2W
10W
9M
40.37
-0.49
(-1.20%)
At close: 04:00PM EDT
40.37
0.00
(0.00%)
After hours:
05:39PM EDT
Summary
Company Insights
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Subscribe to Yahoo Finance Plus Essential to download historical data
Download
Income Statement
Expand All
All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Learn more
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
829,253
829,253
660,116
443,310
267,594
Cost of Revenue
192,361
192,361
139,304
81,413
43,367
Gross Profit
636,892
636,892
520,812
361,897
224,227
Operating Expense
299,318
299,318
253,281
85,995
79,972
Operating Income
337,574
337,574
267,531
275,902
144,255
Net Non Operating Interest Income Expense
-18,762
-18,762
-16,947
-7,526
-20,378
Other Income Expense
29,517
29,517
-1,666
-19,858
5,425
Pretax Income
348,329
348,329
248,918
248,518
129,302
Tax Provision
66,735
66,735
46,789
-154,192
217
Net Income Common Stockholders
281,594
281,594
202,129
402,710
129,085
Diluted NI Available to Com Stockholders
281,594
281,594
202,129
402,710
129,085
Basic EPS
1.91
-
1.48
2.86
0.95
Diluted EPS
1.87
-
1.44
2.74
0.91
Basic Average Shares
133,489
-
136,844
140,646
136,206
Diluted Average Shares
136,269
-
140,608
146,796
141,463
Total Operating Income as Reported
337,574
337,574
267,531
275,902
144,255
Total Expenses
491,679
491,679
392,585
167,408
123,339
Net Income from Continuing & Discontinued Operation
281,594
281,594
202,129
402,710
129,085
Normalized Income
257,732
257,732
203,482
417,206
123,669
Interest Expense
18,762
18,762
16,947
7,526
20,378
Net Interest Income
-18,762
-18,762
-16,947
-7,526
-20,378
EBIT
367,091
367,091
265,865
256,044
149,680
EBITDA
451,947
451,947
315,506
259,041
152,964
Reconciled Cost of Revenue
181,278
181,278
132,811
78,416
43,367
Reconciled Depreciation
84,856
84,856
49,641
2,997
3,284
Net Income from Continuing Operation Net Minority Interest
281,594
281,594
202,129
402,710
129,085
Total Unusual Items Excluding Goodwill
29,517
29,517
-1,666
-19,858
5,425
Total Unusual Items
29,517
29,517
-1,666
-19,858
5,425
Normalized EBITDA
422,430
422,430
317,172
278,899
147,539
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
5,655
5,655
-313.1572
-5,362
9.1045
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.